Safety of Grammidin throat spray in healthy adults
Part of Ear, nose & throat, Infections, Lungs & breathing, Mouth & dental clinical trials.
This trial tests the safety and how the body processes a new throat spray called Grammidin. Healthy volunteers will use the spray so researchers can see how it works and if there are any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 45 years old
- In good health with no major medical conditions
- Blood pressure, heart rate, and body weight within specific healthy ranges
- No use of certain medications, alcohol, or tobacco for several days or weeks before the trial
- Agree to use effective birth control during and 30 days after the study (for women) and not be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new throat spray called Grammidin With Anesthetic to see if it is safe and how the body processes it. Healthy volunteers take the spray and are monitored for side effects and drug levels in the blood.
This trial tests a new spray with anesthetic for sore throat caused by infections like pharyngitis. It compares the spray to a lozenge (Septolete Total) to see which works better and is safer.
This trial tests a new nasal spray (called LMN-1001) in healthy adults to see if it is safe and how the body handles it. It is an early-phase study, so the main goal is not to treat a disease but to check for safety and side effects.
This study tests a new nasal spray (DMI019) in healthy volunteers to see if it is safe and how the body handles it. Participants will receive a single dose and be monitored for a few weeks.
This trial tests a new nose spray called HY-133 to see if it's safe and can clear a common type of staph bacteria from the nose. It is for people who have this bacteria but not the antibiotic-resistant kind.
This study tests whether a new antibody treatment can safely stop strep throat infections. Healthy adults aged 18-40 will receive the antibody and then be exposed to the strep bacteria in a controlled setting to see if it protects them.
Hear when a new Pharyngitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.